Advanced search
Publication Cover
Acta Cardiologica Volume 76, 2021 - Issue 2
Submit an article Journal homepage
154
Views
4
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Assessment of subclinical left ventricular dysfunction with speckle-tracking echocardiography in hyperthyroid and euthyroid Graves’ disease and its correlation with serum TIMP-1

Irfan Veysel Duzena Department of Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, TurkeyCorrespondence[email protected]
,
Suzan Taburb Department of Endocrinology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
Sadettin Ozturkb Department of Endocrinology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
Mert Deniz Savcilioglua Department of Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
Enes Alıca Department of Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
Mustafa Yetisena Department of Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
Sıddık Sanlia Department of Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
Huseyin Goksulukc Bursa Private Anatolian Hospital, Bursa, Turkey
,
Ertan Vuruskana Department of Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
Gokhan Altunbasa Department of Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
Fatma Yılmaz Coskuna Department of Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
Mehmet Kapland Adana City Training and Research Hospital, Adana, Turkey
,
Seyithan Taysie Department of Biochemistry, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
&
Murat Sucua Department of Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
 show all
Pages 177-184 | Received 12 Aug 2019, Accepted 19 Dec 2019, Published online: 07 Jan 2020

References

  • Smith TJ, Hegedus L. Graves' disease. N Engl J Med. 2016;375(16):1552–1565.
  • Biondi B, Palmieri EA, Lombardi G, et al. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab. 2002;87(3):968–974.
  • Cameli M, Mandoli GE, Sciaccaluga C, et al. More than 10 years of speckle tracking echocardiography: still a novel technique or a definite tool for clinical practice? Ecochardiography. 2019;36(5):958–970.
  • Potter E, Marwick TH. Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc Imaging. 2018;11(2):260–274.
  • Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation. 2013;128(4):388–400.
  • López B, González A, Díez J. Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation. 2010;121(14):1645–1654.
  • Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010;1803(1):55–71.
  • Taskina S, Kharintseva SV, Matrix M. 1,-13 and their tissue inhibitor-1 in endocrine ophtalmophaty. Probl Endokrinol (Mosk). 2019;65(1):10–18.
  • Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.
  • Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55(4):613–618.
  • Elnakish MT, Ahmed AA, Mohler PJ, et al. Role of oxidative stress in thyroid hormone-induced cardiomyocyte hypertrophy and associated cardiac dysfunction: an undisclosed story. Oxid Med Cell Longev. 2015; 2015:854265.
  • Barreto-Chaves MLM, Carrillo-Sepúlveda MA, Carneiro-Ramos MS, et al. The crosstalk between thyroid hormones and the renin-angiotensin system. Vascul Pharmacol. 2010;52(3–4):166–170.
  • Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid. 2002;12(10):855–860.
  • Enzmann DR, Donaldson SS, Kriss JP. Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr. 1979;3(6):815–819.
  • Smith TJ. The insulin-like growth factor-I receptor and its role in thyroid associated ophthalmopathy. Eye (Lond). 2019;33(2):200–205.
  • Douglas PS. The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol. 2003;42(7):1206–1207.
  • Smit JW, Eustatia-Rutten CF, Corssmit EP, et al. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2005;90(11):6041–6047.
  • Aroditis K, Pikilidou M, Vourvouri E, et al. Changes in cardiac function and structure in newly diagnosed Graves' disease. A conventional and 2D-speckle tracking echocardiography study. Int J Cardiovasc Imaging. 2017;33(2):187–195.
  • Ojamma K. Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy. Vascul Pharmacol. 2010;52(3–4):113–119.
  • Dörr M, Wolff B, Robinson DM, et al. The association of thyroid function with cardiac mass and left ventricular hypertrophy. J Clin Endocrinol Metab. 2005;90(2):673–677.
  • Ng ACT, Bertini M, Ewe SH, et al. Defining subclinical myocardial dysfunction and implications for patients with diabetes mellitus and preserved ejection fraction. Am J Cardiol. 2019;124(6):892–898.
  • Brandt F, Thvilum M, Almind D, et al. Graves' disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study. Thyroid. 2013;23(4):408–413.
  • Ries C. Cytokine functions of TIMP-1. Cell Mol Life Sci. 2014;71(4):659–672.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.